Syndrome caused by partial chromosomal deletion
MONDO:0000761A chromosomal disorder consisting of the absence of a part of a chromosome.
Also known as: microdeletion syndrome, chromosomal deletion syndrome
57 clinical trials for this condition and its sub-types, 0 tagged with Syndrome caused by partial chromosomal deletion itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Syndrome caused by partial chromosomal deletion
-
Partial deletion of chromosome 7 0 trials · 18 incl. sub-types
2 sub-types
- Partial deletion of the long arm of chromosome 7 0 trials · 18 incl. sub-types Sub-types →
- Partial deletion of the short arm of chromosome 7 0 trials Sub-types →
-
Chromosome 22q deletion 0 trials · 13 incl. sub-types
2 sub-types
- 22q11.2 deletion syndrome 7 trials · 13 incl. sub-types Sub-types →
- Phelan-McDermid syndrome due to 22q13.3 deletion 0 trials
-
Partial deletion of chromosome 17 0 trials · 12 incl. sub-types
2 sub-types
- Chromosome 17p deletion 6 trials · 11 incl. sub-types Sub-types →
- Partial deletion of the long arm of chromosome 17 0 trials · 1 incl. sub-types Sub-types →
-
Smith-Magenis syndrome 5 trials
-
Partial chromosome Y deletion 0 trials · 5 incl. sub-types
3 sub-types
- Spermatogenic failure, Y-linked, 2 5 trials
- Y chromosome infertility due to DAZ1 deletion 0 trials
- Spermatogenic failure, Y-linked, 1 0 trials
-
Partial deletion of chromosome 5 0 trials · 5 incl. sub-types
2 sub-types
- Partial deletion of the long arm of chromosome 5 0 trials · 4 incl. sub-types Sub-types →
- Partial deletion of the short arm of chromosome 5 0 trials · 2 incl. sub-types Sub-types →
-
Partial deletion of the long arm of chromosome 15 1 trial · 3 incl. sub-types
9 sub-types
- Chromosome 15q13.3 microdeletion syndrome 1 trial
- Chromosome 15q24 deletion syndrome 1 trial
- Deafness-infertility syndrome 1 trial
- 15q14 microdeletion syndrome 0 trials
- Angelman syndrome due to maternal 15q11q13 deletion 0 trials
- Prader-Willi syndrome due to paternal 15q11q13 deletion 0 trials Sub-types →
- Chromosome 15q11.2 deletion syndrome 0 trials
- Chromosome 15q25 deletion syndrome 0 trials
- Chromosome 15q26-qter deletion syndrome 0 trials
-
Partial deletion of chromosome 2 0 trials · 2 incl. sub-types
2 sub-types
- Partial deletion of the long arm of chromosome 2 0 trials · 2 incl. sub-types Sub-types →
- Partial deletion of the short arm of chromosome 2 0 trials Sub-types →
-
Partial deletion of chromosome 1 0 trials · 1 incl. sub-types
2 sub-types
- Chromosome 1q deletion 0 trials · 1 incl. sub-types Sub-types →
- Partial deletion of the short arm of chromosome 1 0 trials Sub-types →
-
Partial deletion of chromosome 10 0 trials · 1 incl. sub-types
2 sub-types
- Partial deletion of the short arm of chromosome 10 0 trials · 1 incl. sub-types Sub-types →
- Partial monosomy of the long arm of chromosome 10 0 trials Sub-types →
-
Partial deletion of chromosome 11 0 trials · 1 incl. sub-types
2 sub-types
- Partial deletion of the short arm of chromosome 11 0 trials · 1 incl. sub-types Sub-types →
- Partial deletion of the long arm of chromosome 11 0 trials Sub-types →
-
Partial deletion of chromosome 16 0 trials · 1 incl. sub-types
2 sub-types
- Partial deletion of the short arm of chromosome 16 0 trials · 1 incl. sub-types Sub-types →
- Partial deletion of the long arm of chromosome 16 0 trials Sub-types →
-
Partial deletion of chromosome 3 0 trials · 1 incl. sub-types
3 sub-types
- Partial deletion of the long arm of chromosome 3 0 trials · 1 incl. sub-types Sub-types →
- Blepharophimosis-ptosis-epicanthus inversus syndrome plus 0 trials
- Partial deletion of the short arm of chromosome 3 0 trials Sub-types →
-
Partial deletion of chromosome 8 0 trials · 1 incl. sub-types
2 sub-types
- Partial deletion of the long arm of chromosome 8 0 trials · 1 incl. sub-types Sub-types →
- Partial deletion of the short arm of chromosome 8 0 trials Sub-types →
-
3q27.3 microdeletion syndrome 0 trials
-
Partial deletion of chromosome 12 0 trials
2 sub-types
-
Partial deletion of chromosome 18 0 trials
2 sub-types
- Chromosome 18p deletion syndrome 0 trials
- Chromosome 18q deletion syndrome 0 trials Sub-types →
-
Partial deletion of chromosome 19 0 trials
2 sub-types
-
Partial deletion of chromosome 20 0 trials
2 sub-types
-
Partial deletion of chromosome 4 0 trials
2 sub-types
-
Partial deletion of chromosome 6 0 trials
2 sub-types
-
Partial deletion of chromosome 9 0 trials
3 sub-types
-
Partial deletion of chromosome X 0 trials
2 sub-types
-
5 sub-types
- 13q12.3 microdeletion syndrome 0 trials
- Chromosome 13q14 deletion syndrome 0 trials
- Chromosome 13q33-q34 deletion syndrome 0 trials
- Distal monosomy 13q 0 trials
- Monosomy 13q34 0 trials
-
6 sub-types
- 14q12 microdeletion syndrome 0 trials
- 14q24.1q24.3 microdeletion syndrome 0 trials
- Frias syndrome 0 trials
- Chromosome 14q11-q22 deletion syndrome 0 trials
- Distal monosomy 14q 0 trials
- Paternal 14q32.2 microdeletion syndrome 0 trials
-
2 sub-types
Most studied deeper sub-types
-
Tailored Three-Drug combo targets Myeloma's toughest genetic weak spot
Disease control OngoingResearchers are testing whether a combination of daratumumab, pomalidomide and dexamethasone can help people whose multiple myeloma has come back and carries a genetic change called del(17p). This change, found in about 10% of patients at diagnosis, makes the cancer harder to tre…
Phase 2 • Sponsor: Fondazione EMN Italy Onlus • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Radioactive microspheres aimed at prostate cancer: early safety trial underway
Disease control OngoingThis early study tests the safety of TheraSphere PCa, tiny radioactive glass beads injected into the prostate to treat localized prostate cancer. The trial involves 36 men with favorable intermediate-risk cancer and aims to find the maximum safe radiation dose. Researchers will m…
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
New hope for Tough-to-Treat blood cancers: targeted pill shows promise
Disease control OngoingThis phase 2 trial tests the drug venetoclax (a pill) in 110 people with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). The study includes two groups: those with a specific genetic change (17p deletion) and those who have failed oth…
Phase 2 • Sponsor: AbbVie • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Can early parent coaching help infants with rare genetic disorders thrive?
Disease control By invitation onlyThis study tests a program called PIXI that coaches parents of infants diagnosed with rare neurogenetic disorders (such as Fragile X, Angelman, or Down syndrome) during the first year of life. The program combines education about the disorder, guided parent-child interaction acti…
Sponsor: RTI International • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Fertility drug trial for men with no sperm pulled before it began
Disease control CancelledThis study aimed to see if the drug clomiphene citrate could help men with a condition called non-obstructive azoospermia, where the body produces little to no sperm. The plan was to give the drug or a placebo for nine months, then check if sperm could be found in the semen or th…
Phase 3 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can acne drug or hormone shots help men with low sperm count?
Disease control By invitation onlyThis study tests two treatments—isotretinoin (an acne medication) and hCG (a hormone)—to see if they can help men with low or no sperm count produce moving sperm. About 100 men aged 19 to 50 will take one of the drugs for three months. The goal is to find new options for male inf…
Phase 2 • Sponsor: University of Nebraska • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
Could an allergy drug boost brain function in williams syndrome?
Disease control OngoingThis phase 2 trial tests whether clemastine, a common allergy medication, can improve thinking, motor skills, and social abilities in people with Williams syndrome. The study includes 30 participants aged 6 to 30 and uses a double-blind, placebo-controlled design to measure safet…
Phase 2 • Sponsor: Sheba Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Milder stem cell transplant shows promise for kids with immune disorders
Disease control OngoingThis study tests a stem cell transplant using a milder chemotherapy-like regimen to treat children and young adults (up to age 28) with various immune system disorders. The goal is to help the donor stem cells settle in the body with fewer side effects. The study involves 20 part…
Phase 2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Double transplant breakthrough offers hope for rare immune disorder patients
Disease control By invitation onlyThis study tests a new approach for people aged 5 to 45 with primary immune deficiencies and end-stage lung disease. Participants receive a double lung transplant followed by a stem cell transplant from the same donor. The goal is to see if this combined procedure is safe and can…
Phase 1/2 • Sponsor: Paul Szabolcs • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Can a video-based therapy tame tough behaviors in kids with rare genetic disorders?
Symptom relief OngoingThis study tests a virtual behavioral therapy (Functional Behavioral Training) for children aged 2-12 with genetic syndromes like Fragile X, Angelman, or Rett syndrome who have challenging behaviors. The therapy teaches parents how to identify what triggers problem behaviors and …
Sponsor: Rush University Medical Center • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
New program aims to ease burden on families of kids with rare diseases
Symptom relief By invitation onlyThis study tests a program called FACE-Rare, designed to support family caregivers of children with rare, life-limiting diseases. The program includes three sessions to help families prepare for future medical decisions and improve their quality of life. Researchers will compare …
Sponsor: Children's National Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Zapped nerves: study planned to boost recovery after surgery — but never started
Knowledge-focused CancelledThis study was designed to see if giving a short, mild electrical stimulation to compressed nerves during surgery could speed up recovery of strength and function. It planned to include people with nerve compression in the spine or limbs who were already scheduled for decompressi…
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Prostate cancer recurrence study pulled before it even started
Knowledge-focused CancelledThis study aimed to test a focused radiation treatment (HDR brachytherapy) for men whose prostate cancer returned only in the prostate gland after earlier radiation therapy. It planned to enroll adults with biopsy-confirmed recurrence seen on a special PET scan. However, the stud…
Sponsor: University of Rochester • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC